[ad_1]
Israel will begin offering the fourth dose of coronavirus to some of its citizens, the first country, as concerns about the current Omicron shooting continue around the world.
“Israel will be the first country in the world to host a fourth [dose of a] Covid19 vaccine. The first eligible group will be people over 60 years of age [and over and] medical personnel, “the Israeli government said of the epidemic Twitter late Tuesday.
The ruling, he said, would provide “greater security in the eyes of Omicron”.
Israel has been identified as the first coronavirus vaccine trial to reach the highest levels of bios and bioNTech / Pfizer that were shot earlier this year. Then it began to increase population growth in the summer as the Delta species swept the country.
Prime Minister Naftali Bennett has ordered the country to prepare for a major international campaign that will give new jabs four months after the re-launch of their third parade.
“This is very good news that will help us cross Omicron’s waves around the world,” he said on Tuesday while warning that Israel is at risk of the fifth plague.
“Israeli citizens were the first in the world to receive the third Covid-19 vaccine and we are continuing to pioneer at the fourth level,” Bennett said.
Israel has about 350 cases of Omicron confirmation, with another 800 suspicious, but it wants a wave similar to that of London and New York, health officials have warned.
When Omicron began to spread last month, Israel closed its borders in an attempt to curb the spread.
The richest countries in the world are starting to offer the third mRNA vaccine to the general public, the first evidence being found that the two existing doses of vaccines produce fewer Omicron antibodies compared to older models.
It is still unknown how this will turn out to be effective, although health officials around the world have shown that modern vaccines may not be effective in fighting the disease. highly flexible and contagious was first identified in southern Africa last month.
Preliminary evidence suggests that a higher level of mRNA may contribute to the development of antibodies, which may provide greater protection against fewer infections. Scientists still hope that the two shots will continue to protect against the most serious consequences.
Many manufacturers of Covid-19 vaccine, inclusive Oxford / AstraZeneca, BioNTech / Pfizer and Moderna, have begun work on developing and testing the Omicron vaccine if needed.
The fourth level is not recommended anywhere. Supervisors around the world, such as the European Medicines Agency, say they are considering four shortcuts in small groups at risk, such as those with no immune system.
[ad_2]
Source link
